Clinical trial
RAPDx Pupillography for Early Detection of Glaucoma
NCT02526693 is registered in ClinicalTrials.gov with Wills Eye as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- RAPDx Pupillography for Early Detection of Glaucoma
- Lead sponsor
- Wills Eye
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- June 30, 2014
- Completion date
- August 31, 2015
- Enrollment
- 104 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.